![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
STI Lab Surveillance: Quarterly Reports 2003-2018 |
Sunday 26th June 2022 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]()
|
![]() |
ESR undertakes STI surveillance on behalf of the Ministry of Health. A number of different surveillance systems are currently in place including notifications, laboratory-based surveillance and clinic-based surveillance. These reports present data on laboratory tests for chlamydia and gonorrhoea for the period 2003-2018. All New Zealand laboratories were reporting from 2015 onwards. Since 2019 the quarterly STI laboratory data has been presented in a dashboard format in the link below: https://www.esr.cri.nz/our-services/consultancy/public-health/sti/
|
![]() |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |